Astrazeneca won an agreement on vaccines against the coronavirus, including Germany and France


The contract covers up to 400 million doses of the vaccine, developed by the University of Oxford, said the company, adding that it has sought to expand the manufacture of the vaccine, that it is committed to provide no benefit during the pandemic.”With our supply chain, the european union, which should begin production soon, we hope to make the vaccine available widely and quickly,” said chief executive officer Pascal Soriot in a statement.

The experimental phase of the vaccine is already advanced and should be completed in the autumn, said the Italian minister of Health Roberto Speranza in a post Facebook.

AstraZeneca has agreed to agreements of global manufacturing to achieve its goal of producing 2 billion doses of the vaccine, including two companies backed by Bill Gates and an agreement of $ 1.2 billion with the u.s. government.

There is no vaccine or approved treatment for COVID-19, the respiratory disease is highly contagious, caused by the new coronavirus.

“Many countries in the world have already gotten vaccines, Europe has not yet done so. The prompt co-ordinated action of a group of member States will create an added value for all citizens of the EU in this crisis, ” said the German minister of Health, Jens Spahn.

The european Commission received on Friday a mandate from EU governments to negotiate anticipated purchases of promising vaccines against the coronavirus, said the top official of the health of the EU, but it was not clear whether there would be enough money available.



Please enter your comment!
Please enter your name here